Effect of Remazolam Besylate Combined With Remifentanil Analgesic Sedation on the Prognosis of Patients With Sepsis
Clinical trial NCT06731088 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06731088
- Sponsor
- First Affiliated Hospital of Ningbo University
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2025-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.